ID: ALA3770204

Max Phase: Preclinical

Molecular Formula: C34H41F6N7O2

Molecular Weight: 693.74

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C[C@@H](NC(=O)N2CCN(c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)C(=O)N2CCC(N3CCCCC3)CC2)cc2cn[nH]c12

Standard InChI:  InChI=1S/C34H41F6N7O2/c1-22-15-23(16-24-21-41-43-30(22)24)17-29(31(48)46-9-5-27(6-10-46)44-7-3-2-4-8-44)42-32(49)47-13-11-45(12-14-47)28-19-25(33(35,36)37)18-26(20-28)34(38,39)40/h15-16,18-21,27,29H,2-14,17H2,1H3,(H,41,43)(H,42,49)/t29-/m1/s1

Standard InChI Key:  JUGMJOLTIQPRJM-GDLZYMKVSA-N

Associated Targets(Human)

Calcitonin gene-related peptide 1 214 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 693.74Molecular Weight (Monoisotopic): 693.3226AlogP: 5.83#Rotatable Bonds: 6
Polar Surface Area: 87.81Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.36CX Basic pKa: 9.62CX LogP: 4.86CX LogD: 2.65
Aromatic Rings: 3Heavy Atoms: 49QED Weighted: 0.32Np Likeness Score: -1.29

References

1. Civiello RL, Han X, Beno BR, Chaturvedula PV, Herbst JJ, Xu C, Conway CM, Macor JE, Dubowchik GM..  (2016)  Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines.,  26  (4): [PMID:26832218] [10.1016/j.bmcl.2016.01.026]

Source